Bank of New York Mellon’s Merck MRK Stock Holding History

Bank of New York Mellon’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-1,362	Closed	-$69K	–	4269
2015 Q4	$69K	Sell	1,362 -210	-13%	-$10.6K	﹤0.01%	4131
2015 Q3	$74K	Buy	1,572 +1,537	+4,391%	+$81.6K	﹤0.01%	4186
2015 Q2	$2K	Buy	+35	New	+$1.96K	﹤0.01%	4288
2014 Q4	–	Sell	-629	Closed	-$36K	–	4272
2014 Q3	$36K	Buy	+629	New	+$35.3K	﹤0.01%	4172
2014 Q2	–	Sell	-314	Closed	-$17K	–	4222
2014 Q1	$17K	Hold	314	–	–	﹤0.01%	4152
2013 Q4	$15K	Hold	314	–	–	﹤0.01%	4179
2013 Q3	$14K	Hold	314	–	–	﹤0.01%	4126
2013 Q2	$14K	Buy	+314	New	+$14K	﹤0.01%	4127

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Bank of New York Mellon's MRK Position: Q2 2026 in Review

Bank of New York Mellon reduced its Merck (MRK) stake by 2% in Q2 2026, selling an estimated $43.7M and leaving 18,340,173 shares worth $2.36B. The position accounts for 0.39% of the portfolio, ranked #44.

Bank of New York Mellon first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.54B in Q3 2016. 3,094 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Bank of New York Mellon held 18,340,173 shares of Merck worth $2.36B as of Q2 2026.
Bank of New York Mellon sold 373,190 Merck shares in Q2 2026, an estimated $43.7M.
Merck made up 0.39% of Bank of New York Mellon's portfolio in Q2 2026, its #44 holding.
Bank of New York Mellon first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
Bank of New York Mellon's Merck position peaked at $3.54B in Q3 2016.
3,094 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.